Journal of Peking University(Health Sciences) ›› 2020, Vol. 52 ›› Issue (1): 30-34. doi: 10.19723/j.issn.1671-167X.2020.01.005

Previous Articles     Next Articles

Cervical lymph node metastasis in adenoid cystic carcinoma of the salivary glands: A clinicopathologic study

Ye ZHANG,Ni ZHANG,Xiao-xiao LIU,Chuan-xiang ZHOU()   

  1. Department of Oral Pathology, Peking University School and Hospital of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China
  • Received:2019-10-14 Online:2020-02-18 Published:2020-02-20
  • Contact: Chuan-xiang ZHOU E-mail:zhoucx2008@126.com
  • Supported by:
    Supported by Beijing Nature Science Foundation(7192232)

RICH HTML

  

Abstract:

Objective: To investigate the incidence and clinicopathologic features of cervical lymph node metastasis in salivary gland adenoid cystic carcinoma (AdCC). Methods: Retrospective analysis was made in 798 AdCC patients who underwent tumor resection during January, 2001 to January, 2019 in Peking University School and Hospital of Stomatology, especially the clincopathologic characteristics of 82 cases with lymph node metastasis. Results: In the study, 82 of the 798 patients were identified with cervical lymph node metastasis, which was confirmed by histopathological examination. The palate, the region of sublingual gland and mouth floor, and the parotid were the frequently involved primary sites for AdCCs. The general incidence rate of lymph node metastasis was approximately 10%. The submandibular gland, the region of sublingual gland and mouth floor, and the mobile tongue were the most frequent sites of lymph node metastasis with the incidence rates of 20.8%, 16.1%, and 15.1%, respectively; while lymph node metastasis was uncommon in the tumors which were the origin from the palate and parotid, with incidence rates of 6.1% and 3.4%, respectively. Most AdCC cases (70.7%) showed the classic “tunnel-style” metastatic pattern of occurrence, and the level Ⅰ and Ⅱ regions were the most frequently involved areas. The 5-year and 10-year overall survival rates of the patients with lymph node metastasis were 77.4% and 20.6% respectively, while the 5-year and 10-year overall survival rates of the patients with no lymph node metastasis were 83.5% and 57.6%, respectively. The univariate analysis demonstrated that statistically significant differences in the overall survival for the presence of lymph node metastasis (P<0.001). In the meantime, the 5-year disease-free survival rate of the patients with lymph node metastasis also showed statistically significant differences to that of the AdCC patients with no lymph node metastasis. In addition, the primary site and histological grade were significantly associated with lymph node metastasis, and the high-grade solid growth pattern was identified as a strong predictor for the occurrence of lymph node metastasis. Conclusion: Cervical lymph node metastasis has a high tendency of occurrence in submandibular gland and tongue-mouth floor complex, and the high-grade solid growth pattern could be taken as a strong predictor for the occurrence of lymph node metastasis, which correlates to poor prognosis of AdCC patients. A selective neck dissection should be considered as a ma-nagement in such patients.

Key words: Salivary glands, Carcinoma, adenoid cystic, Lymph nodes, Metastasis, Pathology, clinical

CLC Number: 

  • R739.87

Figure 1

Distribution of primary sites of AdCC patients"

Table 1

The relationship of lymph node metastasis with clinicopathologic characteristics"

Characteristic Lymph node status P
Positive (+) Negative (-)
Age 0.816
≤50 years old 41 344
>50 years old 41 372
Gender 0.409
Male 38 296
Female 44 420
Tumor size 0.345
≤3 cm 58 542
>3 cm 24 174
Perineural invasion 0.264
Yes 60 475
No 22 241
Tumor site <0.001
Submandibular gland 25 95
Other sites 57 621
Histological grade <0.001
Tubular-cribriform 37 622
Solid 45 94

Figure 2

Incidence of lymph node metastasis in AdCC patients according to the primary site"

Figure 3

Invasion to the lymph node and classic “tunnel-style” metastasis pattern A, tumor cells directly invading to the lymph node in the submandibular region, with both extra- and intra- metastasized tumor cells (HE ×4); B, classic “tunnel-style” metastasis pattern (HE ×4)."

Figure 4

Pathological features of metastatic lymph nodes A, metastasized AdCC cells (cribriform pattern) beside the node envelope (HE ×40); B, tumor cells (cribriform pattern) in the metastatic lymph node (HE ×100); C and D, metastasized AdCC cells (solid pattern) distributing sporadically in the lymphatic sinuses (HE ×100)"

Figure 5

Kaplan-Meier analysis of the overall survival of AdCC patients with/without lymph node metastasis"

[1] Tian Z, Li L, Wang L , et al. Salivary gland neoplasms in oral and maxillofacial regions: A 23-year retrospective study of 6 982 cases in an eastern Chinese population[J]. Int J Oral Maxillofac Surg, 2010,39(3):235-242.
[2] Gao M, Hao Y, Huang MX , et al. Clinicopathological study of distant metastases of salivary adenoid cystic carcinoma[J]. Int J Oral Maxillofac Surg, 2013,42(8):923-928.
[3] Shen C, Xu T, Huang C , et al. Treatment outcomes and prognostic features in adenoid cystic carcinoma originated from the head and neck[J]. Oral Oncol, 2012,48(5):445-449.
[4] Lloyd S, Yu JB, Wilson LD , et al. Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy[J]. Am J Clin Oncol, 2011,34(1):76-81.
[5] Bhayani MK, Yener M, El-Naggar A , et al. Prognosis and risk factors for early-stage adenoid cystic carcinoma of the major salivary glands[J]. Cancer, 2012,118(11):2872-2878.
[6] Armstrong JG, Harrison LB, Thaler HT , et al. The indications for elective treatment of the neck in cancer of the major salivary glands[J]. Cancer, 1992,69(3):615-619.
[7] Suárez C, Barnes L, Silver CE , et al. Cervical lymph node metastasis in adenoid cystic carcinoma of oral cavity and oropharynx: A collective international review[J]. Auris Nasus Larynx, 2016,43(5):477-484.
[8] Ardekian L, Kokemueller H, Eckardt A , et al. Adenoid cystic carcinoma of the head and neck: A 20 years experience[J]. Int J Oral Maxillofac Surg, 2004,33(1):25-31.
[9] Bianchi B, Copelli C, Cocchi R , et al. Adenoid cystic carcinoma of intraoral minor salivary glands[J]. Oral Oncol, 2008,44(11):1026-1031.
[10] Coca-Pelaz A, Rodrigo JP, Bradley PJ , et al. Adenoid cystic carcinoma of the head and neck: An update[J]. Oral Oncol, 2015,51(7):652-661.
[11] Zhang M, Xu ZF, Tao Y , et al. Clinical analysis of 25 patients with glossal adenoid cystic carcinoma[J]. Int J Stomt, 2009,36(2):148-151.
[12] Min R, Siyi L, Wenjun Y , et al. Salivary gland adenoid cystic carcinoma with cervical lymph node metastasis: A preliminary study of 62 cases[J]. Int J Oral Maxillofac Surg, 2012,41(8):952-957.
[13] Amit M, Binenbaum Y, Sharma K , et al. Incidence of cervical lymph node metastasis and its association with outcomes in patients with adenoid cystic carcinoma. An international collaborative study[J]. Head Neck, 2015,37(7):1032-1037.
[14] Weinreb I, Lee SY, Kim BH , et al. Nineteen-year oncologic outcomes and the benefit of elective neck dissection in salivary gland adenoid cystic carcinoma[J]. Head Neck, 2014,36(12):1796-1801.
[15] Ali S, Palmer FL, Katabi N , et al. Long-term local control rates of patients with adenoid cystic carcinoma of the head and neck managed by surgery and postoperative radiation[J]. Laryngoscope, 2017,127(10):2265-2269.
[16] Nakada M, Nishizaki K, Akagi H , et al. Oncocytic carcinoma of the submandibular gland: a case report and literature review[J]. J Oral Pathol Med, 1998,27(5):225-228.
[17] Amit M, Na’ara S, Sharma K , et al. Elective neck dissection in patients with head and neck adenoid cystic carcinoma: An international collaborative study[J]. Ann Surg Oncol, 2015,22(4):1353-1359.
[1] Dongwu LIU, Jie CHEN, Mingli GAO, Jing YU. Rheumatoid arthritis with Castleman-like histopathology in lymph nodes: A case report [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 928-931.
[2] Yuxuan TIAN,Mingjian RUAN,Yi LIU,Derun LI,Jingyun WU,Qi SHEN,Yu FAN,Jie JIN. Predictive effect of the dual-parametric MRI modified maximum diameter of the lesions with PI-RADS 4 and 5 on the clinically significant prostate cancer [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 567-574.
[3] Shuai LIU,Lei LIU,Zhuo LIU,Fan ZHANG,Lulin MA,Xiaojun TIAN,Xiaofei HOU,Guoliang WANG,Lei ZHAO,Shudong ZHANG. Clinical treatment and prognosis of adrenocortical carcinoma with venous tumor thrombus [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 624-630.
[4] Fan SHU,Yichang HAO,Zhanyi ZHANG,Shaohui DENG,Hongxian ZHANG,Lei LIU,Guoliang WANG,Xiaojun TIAN,Lei ZHAO,Lulin MA,Shudong ZHANG. Functional and oncologic outcomes of partial nephrectomy for cystic renal cell carcinoma: A single-center retrospective study [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 667-672.
[5] Zezhen ZHOU,Shaohui DENG,Ye YAN,Fan ZHANG,Yichang HAO,Liyuan GE,Hongxian ZHANG,Guoliang WANG,Shudong ZHANG. Predicting the 3-year tumor-specific survival in patients with T3a non-metastatic renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 673-679.
[6] Zhanhong LAI,Jiachen LI,Zelin YUN,Yonggang ZHANG,Hao ZHANG,Xiaoyan XING,Miao SHAO,Yuebo JIN,Naidi WANG,Yimin LI,Yuhui LI,Zhanguo LI. A unicenter real-world study of the correlation factors for complete clinical response in idiopathic inflammatory myopathies [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 284-292.
[7] Junqi SU,Xiaoying WANG,Zhiqiang SUN. Establishment and verification of a prognostic nomogram for survival of tongue squamous cell carcinoma patients who underwent cervical dissection [J]. Journal of Peking University (Health Sciences), 2024, 56(1): 120-130.
[8] Xunmin XU,Xiao SHAO,Aiping JI. Analysis of death cases in the oral emergency department [J]. Journal of Peking University (Health Sciences), 2024, 56(1): 185-189.
[9] Lu FENG,Jia-yu ZHAI,Jin-xia ZHAO. Medical visit status and clinical features in patients with IgG4 related disease [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1028-1032.
[10] Yun-chong LIU,Zong-long WU,Li-yuan GE,Tan DU,Ya-qian WU,Yi-meng SONG,Cheng LIU,Lu-lin MA. Mechanism of nuclear protein 1 in the resistance to axitinib in clear cell renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 781-792.
[11] Dong LAN,Zhuo LIU,Yu-xuan LI,Guo-liang WANG,Xiao-jun TIAN,Lu-lin MA,Shu-dong ZHANG,Hong-xian ZHANG. Risk factors for massive hemorrhage after radical nephrectomy and removal of venous tumor thrombus [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 825-832.
[12] Hui WEI, Ci-dan-yang-zong, Yi-xi-la-mu, Bai-ma-yang-jin. Risk factors associated with different types of Henoch-Schönlein purpura in Tibetan patients at high altitude [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 923-928.
[13] Shang XIE,Zhi-gang CAI,Xiao-feng SHAN. Application value of whole exon sequencing and immune related indicators in the precision treatment of oral squamous cell carcinoma [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 697-701.
[14] Han LU,Jian-yun ZHANG,Rong YANG,Le XU,Qing-xiang LI,Yu-xing GUO,Chuan-bin GUO. Clinical factors affecting the prognosis of lower gingival squamous cell carcinoma [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 702-707.
[15] Yun-fei SHI,Hao-jie WANG,Wei-ping LIU,Lan MI,Meng-ping LONG,Yan-fei LIU,Yu-mei LAI,Li-xin ZHOU,Xin-ting DIAO,Xiang-hong LI. Analysis of clinicopathological and molecular abnormalities of angioimmunoblastic T-cell lymphoma [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 521-529.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!